Literature DB >> 14644113

Handling and pathology reporting of radical prostatectomy specimens.

Rodolfo Montironi1, Theodorus van der Kwast, Liliane Boccon-Gibod, Aldo V Bono, Laurent Boccon-Gibod.   

Abstract

Proper examination of radical prostatectomy (RP) specimens by the pathologists is critical in accurately determining the prediction of patient outcome. The pathology report should include relevant clinical information as well as provide prognostically useful data derived from the evaluation of the RP specimen.

Entities:  

Mesh：

Year:  2003        PMID： 14644113     DOI： 10.1016/s0302-2838(03)00381-6

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  12 in total

Review 1.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

2.  Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).

Authors:  Theodorus H van der Kwast; Laurence Collette; Hein Van Poppel; Paul Van Cangh; Kris Vekemans; Luigi DaPozzo; Jean-François Bosset; Karl H Kurth; Fritz H Schröder; Michel Bolla
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

3.  Stage pT0 after radical prostatectomy: a diagnostic dilemma.

Authors:  Stephanie Schirrmacher; Panagiotis Kallidonis; Lars-Christian Horn; Hans Nenning; Jörg Rassler; Bhavan Rai; Minh Do; Evangelos Liatsikos; Jens-Uwe Stolzenburg
Journal:  World J Urol       Date:  2014-11-23       Impact factor: 4.226

4.  In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Authors:  Anthonius J Breeuwsma; Jan Pruim; Maud M Jongen; Albert J Suurmeijer; Wim Vaalburg; Rien J Nijman; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-12       Impact factor: 9.236

5.  Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?

Authors:  L Van den Bergh; S Isebaert; M Koole; R Oyen; S Joniau; E Lerut; C M Deroose; F De Keyzer; H Van Poppel; K Haustermans
Journal:  Strahlenther Onkol       Date:  2013-09       Impact factor: 3.621

6.  Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer.

Authors:  Hyungwoo Ahn; Sung Il Hwang; Hak Jong Lee; Hyoung Sim Suh; Gheeyoung Choe; Seok-Soo Byun; Sung Kyu Hong; Sangchul Lee; Joongyub Lee
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315

7.  Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.

Authors:  Jan Hrbacek; Michael Urban; Eva Hamsikova; Ruth Tachezy; Vaclav Eis; Marek Brabec; Jiri Heracek
Journal:  BMC Cancer       Date:  2011-02-03       Impact factor: 4.430

8.  Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens.

Authors:  Okyaz Eminaga; Reemt Hinkelammert; Axel Semjonow; Joerg Neumann; Mahmoud Abbas; Thomas Koepke; Olaf Bettendorf; Elke Eltze; Martin Dugas
Journal:  BMC Med Inform Decis Mak       Date:  2010-11-15       Impact factor: 2.796

9.  Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer.

Authors:  Rogier R Wildeboer; Arnoud W Postema; Libertario Demi; Maarten P J Kuenen; Hessel Wijkstra; Massimo Mischi
Journal:  Eur Radiol       Date:  2016-12-21       Impact factor: 5.315

10.  Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.

Authors:  Roberta Mazzucchelli; Francesca Barbisan; Adriano Tagliabracci; Antonio Lopez-Beltran; Liang Cheng; Marina Scarpelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2007-02-07       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.